Nutra Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	0.01	0.04	-	-	0.09	-
Short-Term Investments	0.02	0.02	0.04	-	-	-
Cash & Short-Term Investments	0.03	0.05	0.04	-	0.09	-
Cash Growth	78.65%	53.54%	-	-	-	-
Accounts Receivable	0.04	0.03	0.02	0.02	0.05	0.04
Other Receivables	0.15	0.08	0.04	-	0.01	0
Receivables	0.19	0.11	0.07	0.25	0.33	0.04
Inventory	0.02	0.02	0.02	0.02	0.03	0.01
Prepaid Expenses	0.15	0.03	0.03	0.06	0.07	0.01
Other Current Assets	0.16	0.16	0.16	-	0.02	-
Total Current Assets	0.55	0.37	0.31	0.33	0.53	0.06
Property, Plant & Equipment	0.1	0.1	0.19	0.33	0.14	0.16
Other Long-Term Assets	0.12	0.12	0.13	0.09	0.11	0.09
Total Assets	0.78	0.6	0.64	0.75	0.78	0.3
Accounts Payable	0.82	0.8	0.76	0.73	0.67	0.6
Accrued Expenses	3.36	3.25	2.76	2.36	2.05	2.39
Short-Term Debt	3.63	3.51	2.75	2.07	4.42	2.26
Current Portion of Long-Term Debt	6.61	6.22	6.24	5.98	3.38	2.59
Current Portion of Leases	0.07	0.09	0.08	0.07	0.08	0.08
Current Unearned Revenue	-	-	0.23	0.18	-	-
Other Current Liabilities	2.35	1.39	1.34	1.31	10.54	3.57
Total Current Liabilities	16.85	15.27	14.17	12.7	21.14	11.48
Long-Term Debt	0.14	0.14	0.14	0.25	0.52	0.25
Long-Term Leases	-	-	0.09	0.18	-	0.06
Total Liabilities	16.99	15.41	14.41	13.13	21.66	11.8
Common Stock	7.1	7.1	7.06	7.04	6.77	6.96
Additional Paid-In Capital	53.84	53.84	53.63	53.65	53.6	50.18
Retained Earnings	-77.64	-76.23	-74.95	-73.55	-81.73	-68.63
Comprehensive Income & Other	0.47	0.47	0.47	0.47	0.47	-
Total Common Equity	-16.22	-14.82	-13.78	-12.39	-20.89	-11.5
Shareholders' Equity	-16.21	-14.81	-13.77	-12.38	-20.88	-11.49
Total Liabilities & Equity	0.78	0.6	0.64	0.75	0.78	0.3
Total Debt	10.45	9.96	9.31	8.55	8.4	5.24
Net Cash (Debt)	-10.42	-9.91	-9.27	-8.55	-8.3	-5.24
Net Cash Per Share	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
Filing Date Shares Outstanding	7,160	7,160	7,100	7,100	7,364	7,268
Total Common Shares Outstanding	7,100	7,100	7,065	7,040	7,331	6,955
Working Capital	-16.3	-14.89	-13.86	-12.37	-20.61	-11.43
Book Value Per Share	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
Tangible Book Value	-16.22	-14.82	-13.78	-12.39	-20.89	-11.5
Tangible Book Value Per Share	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
Machinery	0.08	0.06	0.06	0.25	0.19	0.15
Leasehold Improvements	-	-	-	0.07	0.07	0.07

Source: S&P Global Market Intelligence. Standard template. Financial Sources.